The “IDEAS” Study stands for Imaging Dementia-Evidence for Amyloid Scanning. The purpose of this study is to improve the way doctors are able to take images of the brain and better treat dementia and memory-related conditions.
Over 8,000 medicare patients are expected to be in the study, and experienced scientists are conducting it with the Alzheimer’s Association and the American College of Radiology Imaging Network (ACRIN).
Study participants will have an image of their brain taken, called an amyloid PET scan, and a follow-up visit. The physician will fill out two forms regarding the participant’s diagnosis and treatment plan, one during the initial visit and one at the 90-day follow-up. Participant Medicare claims information will be collected for up to three years.
To qualify, participants must:
- Be a Medicare beneficiary, 65 years of age or older.
- Have ongoing memory problems or confusion without a known cause of the symptoms.
- Have a medical history and cognitive testing that supports the diagnosis of either dementia or mild cognitive impairment, but the cause is not clear.
- Have possible Alzheimer’s disease, but their signs are unusual.
Why join the IDEAS Study?
- Receive a PET scan that may assist in future planning and care.
- Your PET scan will be covered by Medicare. As with any medical service covered by Medicare, you will still be responsible for any deductible or co-payment require for the service, depending on other coverage.
For more information about this research study call : (561) 282-5538 or email using form below: